Literature DB >> 33552078

Bactericidal Permeability Increasing Protein Deficiency Aggravates Acute Colitis in Mice by Increasing the Serum Levels of Lipopolysaccharide.

Qingli Kong1, Zhe Lv1, Yun Kang2, Yunqing An1, Zhenlong Liu1, Jianmin Zhang3.   

Abstract

Objective: The objective of this study was to understand the role of bactericidal permeability increasing protein (BPI) in the pathogenesis of experimental murine colitis.
Methods: We used the Cre-LoxP system to generate BPI knockout (BPI KO) mice. Acute colitis was induced in BPI KO mice and wild-type (WT) mice by subjecting the mice to 5% dextran sulfate sodium (DSS). Mice were observed for symptoms of experimental colitis. The survival of BPI KO mice to infection with Acinetobacter baumannii, a gram-negative bacterium, was also assessed.
Results: Southern blot, RT-PCR, and western blot results showed that the 2nd and 3rd exons of the murine Bpi gene were knocked out systemically, confirming successful construction of the BPI KO mouse. BPI KO mice subjected to DSS showed increased symptoms of experimental colitis, increased colonic mucosal damage, increased epithelial permeability, elevated levels of serum LPS, and a disrupted fecal microbiome as compared with WT mice. Furthermore, BPI KO mice challenged intraperitoneally with A. baumannii died sooner than WT mice, and the total number of bacteria in the abdominal cavity, spleen, and liver was increased in BPI KO mice as compared to WT mice. Conclusions: We successfully generated BPI KO mice. The BPI KO mice developed worse colitis than WT mice by increased colitis symptoms and colonic mucosal damage, elevated levels of serum LPS, and a disrupted microbiome. BPI could be a potential target for treatment of ulcerative colitis in humans.
Copyright © 2021 Kong, Lv, Kang, An, Liu and Zhang.

Entities:  

Keywords:  antibacterial peptide; bactericidal permeability-increasing protein; gene knockout; gram negative bacteria; ulcerative colitis

Year:  2021        PMID: 33552078      PMCID: PMC7858664          DOI: 10.3389/fimmu.2020.614169

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  26 in total

1.  A novel role for the bactericidal/permeability increasing protein in interactions of gram-negative bacterial outer membrane blebs with dendritic cells.

Authors:  Hendrik Schultz; Janet Hume; De Sheng Zhang; Theresa L Gioannini; Jerrold P Weiss
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice.

Authors:  E M Simpson; C C Linder; E E Sargent; M T Davisson; L E Mobraaten; J J Sharp
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

3.  Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.

Authors:  R S Walmsley; M H Zhao; M I Hamilton; A Brownlee; P Chapman; R E Pounder; A J Wakefield; C M Lockwood
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epithelia.

Authors:  Geraldine Canny; Ofer Levy; Glenn T Furuta; Sailaja Narravula-Alipati; Richard B Sisson; Charles N Serhan; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.

Authors:  Susanne Schinke; Klaus Fellermann; Karen Herlyn; Philipp H Reichel; Rilana Fundke; Eduard F Stange; Wolfgang L Gross; Hendrik Schultz
Journal:  Inflamm Bowel Dis       Date:  2004-11       Impact factor: 5.325

Review 6.  Antimicrobial defense of the intestine.

Authors:  Sohini Mukherjee; Lora V Hooper
Journal:  Immunity       Date:  2015-01-01       Impact factor: 31.745

Review 7.  Diagnosis and classification of ulcerative colitis.

Authors:  Karsten Conrad; Dirk Roggenbuck; Martin W Laass
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

8.  Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein.

Authors:  Andrea Weitz; Russell Spotnitz; Jennifer Collins; Steven Ovadia; Nicole M Iovine
Journal:  Int J Antimicrob Agents       Date:  2013-09-21       Impact factor: 5.283

9.  Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice.

Authors:  Anni Woting; Michael Blaut
Journal:  Nutrients       Date:  2018-05-28       Impact factor: 5.717

10.  Bactericidal permeability increasing protein gene polymorphism is associated with inflammatory bowel diseases in the Turkish population.

Authors:  Güray Can; Hakan Akın; Filiz T Özdemir; Hatice Can; Bülent Yılmaz; Fatih Eren; Özlen Atuğ; Belkıs Ünsal; Hülya O Hamzaoğlu
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

View more
  1 in total

1.  A Polymorphism of Bactericidal/Permeability-Increasing Protein Affects Its Neutralization Efficiency towards Lipopolysaccharide.

Authors:  Katharina U Ederer; Jonas M Holzinger; Katharina T Maier; Lisa Zeller; Maren Werner; Martina Toelge; André Gessner; Sigrid Bülow
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.